Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,527,816 |
Fungicidal 2-aryl-2-cyano-2-(aryloxyalkyl)ethyl-1,2-4-triazoles 2-aryl-2-cyano-2-(aryloxyalkyl)ethyl-1,2,4-triazoles of the formula ##STR1## wherein Ar.sup.1 and Ar.sup.2 are optionally substituted aryl groups which may... |
| US-5,527,815 |
Carboxymethylidenecycloheptimidazole derivatives, method of
manufacturing the same and therapeutic agents... New therapeutic agent of carboxymethylidenecycloheptimidazole derivatives and method for the manufacture thereof are disclosed, which are represented by the... |
| US-5,527,814 |
Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a
medicament for the treatment of amyotrophic... Use of 2-amino-6-(trifluoromethoxy)benzothiazole, or a salt of this compound with a pharmaceutically acceptable acid, for obtaining a medicament intended for the... |
| US-5,527,813 |
Heterocyclic compounds and their preparation and use The present invention relates to therapeutically active azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the... |
| US-5,527,812 |
Cyclic nitrones The present invention is directed to a new class of cyclic nitrones and their use as spin trapping agents. |
| US-5,527,811 |
Isoquinolinyl compounds which are useful in treating cerebral vascular
disorders Compounds represented by the formula: ##STR1## wherein the ring A and the ring B each stand for an optionally substituted benzene ring; Ar stands for an... |
| US-5,527,810 |
Decahydroisoquinoline compounds as excitatory amino acid receptor
antagonists This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological... |
| US-5,527,809 |
Substituted imidazo[4,5-b]pyridines and benzimidazoles Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl... |
| US-5,527,808 |
Fused tricyclic nitrogen containing heterocycles The present invention relates to novel fused tricycylic nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula ##STR1## ... |
| US-5,527,807 |
7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha.
reductase inhibitors useful in the prevention... Described are new 7.beta.-substituted 4-aza-5.alpha.-cholestan-3-ones and related compounds as 5.alpha.-reductase inhibitors. |
| US-5,527,806 |
17.alpha. and 17.beta. substituted acyl 4 aza steroids Invented are 17.beta.-substituted acyl-4-aza analogues of steroidal synthetic compounds, pharmaceutical compositions containing these compounds, and methods for... |
| US-5,527,805 |
Dynemicin analogs: syntheses, methods of preparation and use A fused ring system compound is disclosed that contains an epoxide group on one side of the fused rings and an enediyne macrocyclic ring on the other side of the... |
| US-5,527,804 |
4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or
cholesterol absorption Compounds which inhibit the enzyme cholesterol ester hydrolase (CEH) thus inhibit the formation of esterified cholesterol. Esterified cholesterol is absorbed... |
| US-5,527,803 |
9-purinyl phosphonic acid derivatives This invention relates to novel purine nucleoside phosphorylase inhibitors, to the methods and intermediates for their preparation and to their use as ... |
| US-5,527,802 |
New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a)
pyrimidin-4-ones New uses of certain substituted pyrido[1,2-a]pyrimidin-4-one anti-allergy drugs are made possible by the provision of clear, stable aqueous solutions of same.... |
| US-5,527,801 |
Ameliorant for blood lipid metabolism The present invention is to provide an ameliorant for blood lipid metabolism which comprises as an active ingredient ... |
| US-5,527,800 |
Tricyclic condensed heterocyclic compounds, their production and use A novel compound of the formula: ##STR1## wherein Ar represents an optionally substituted tricyclic condensed benzene ring group which includes at least one... |
| US-5,527,799 |
HIV protease inhibitors useful for the treatment of AIDS Compounds of formula ##STR1## where R.sup.1 and R.sup.2 are independently hydrogen or optionally-substituted C.sub.1-4 alkyl or aryl, or R.sup.1 and R.sup.2... |
| US-5,527,798 |
Pyridazinone derivatives, and insecticidal and miticidal composition The invention provides a pyridazinone derivative having a high insecticidal and miticidal activity against agricultural noxious insects. The pyridazinone... |
| US-5,527,797 |
Process for transport of agents across the skin and compositions and
articles useful therein New and improved method for the transdermal administration of agents is provided utilizing iontophoresis in conjunction with a water-insoluble, stratum... |
| US-5,527,796 |
Thienothiazine derivatives and their use Thienothiazine derivatives of the formula ##STR1## in which X denotes a single bond, a straight chain or branched carbon chain having 1-12 C-atoms in the... |
| US-5,527,795 |
Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase
and ace The present invention relates to certain novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and of ACE. |
| US-5,527,794 |
Pyrido[3,4-b]indole derivatives as serotonergic agents The compound of the formula: ##STR1## where R.sub.1 and R.sub.5 are independently hydrogen, fluorine, chlorine, bromine, iodine, trifluoromethyl, cyano,... |
| US-5,527,793 |
Antibiotic carbapenem compounds The present invention relates to carbapenems and provides a compound of the formula (I) ##STR1## wherein: R.sup.1 is 1-hydroxyethyl, 1-fluoroethyl or... |
| US-5,527,792 |
7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids The invention provides compounds of the formula ##STR1## wherein X is CH.sub.2, S or O; R.sub.1 is a 3 position substituent such as hydrogen, hydroxy, halo, ... |
| US-5,527,791 |
Carbapenem antibiotic compounds The present invention provides a compound of the formula: ##STR1## or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof wherein: A is... |
| US-5,527,790 |
Bis(maltolato)oxovanadium compositions for the treatment of elevated
blood sugar There are provided vanadium compositions for use in the treatment of hypertension, obesity and diabetes, in particular improved oral compositions comprising... |
| US-5,527,789 |
Method of inhibiting carcinogenesis by treatment with
dehydroepiandrosterone and analogs thereof A method of combatting cancer in a subject comprising administering to said subject dehydroepiandrosterone (DHEA) or an analog thereof in an amount effective to... |
| US-5,527,788 |
Method and composition for treating obesity comprising
dehydroepiandrosterone (DHEA), or a derivative thereof,... The invention describes a method and composition for treating obesity or related disorders in animals using an anorectic agent and dehydroepiandrosterone (DHEA).... |
| US-5,527,787 |
Pharmaceutical composition having antiviral and antibacterial activity
and method of administration A novel pharmaceutical composition having anti-bacterial and antiviral activity and method of treating diseases caused by bacterial and viral pathogens through... |
| US-5,527,786 |
Phosphonic diester derivatives The present invention provides a phosphonic diester derivative of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are the same or different and... |
| US-5,527,785 |
Selectin receptor modulating compositions Selectin receptor binding is modulated by a method which utilizes heparin-like oligosaccharides. |
| US-5,527,784 |
Antihyperlipidemic and antiobesity agent comprising levan or hydrolysis
products thereof obtained from... The present invention relates to an antihyperlipidemic and antiobesity agent which has levan and/or a partial hydrolysate of levan as its active ingredient in... |
| US-5,527,783 |
Dry and Porous galenic form based on plants, its method of preparation
and its applications Solid compositions based on plants, capable of being converted to a dry and porous galenic form (lyophilized or equivalent form) which is undivided or powdered.... |
| US-5,527,782 |
5-halo-2,3'-O-cyclocytidines A 5'-halo-2,3'-O-cyclocytidine of Formula I: ##STR1## wherein: X is a bromide, chloride, or iodide; Y is halide, sulfate, acetate, tosyl, mesyl, benzoate, and... |
| US-5,527,781 |
4-O-(aminoglycosyl)- or
4,6-di-O-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivatives As new compounds are now synthetized 5-deoxy-5,5-difluoro derivatives of aminoglycosidic antibiotics of neamine, kanamycin A-series, kanamycin B-series,... |
| US-5,527,780 |
Erythromycin derivatives A compound selected from the group consisting of a compound of the formula ##STR1## wherein R is --(CH.sub.2).sub.n --Ar.sub.1 or --XAr.sub.2, n is an integer ... |
| US-5,527,779 |
Topically applied gold organic complex It has been surprisingly found that gold compounds may be applied in topical preparations as an effective treatment of local or systemic inflammatory conditions... |
| US-5,527,778 |
Method for selective opening of abnormal brain tissue capillaries A method for selectively opening abnormal brain tissue capillaries of a mammal in order to allow selective passage of both low and high molecular weight... |
| US-5,527,777 |
Peptide compounds, in particular LHRH-antagonists The invention concerns LHRH antagonists of the general formula (I), The invention concerns LHRH antagonists of the general formula (I), in which X is an acyl group,... |
| US-5,527,776 |
Treatment of immunologic and hematologic disorders with IGFBP alone or
complexed with IGF This invention includes a method of treating subjects with immunologic and hematologic disorders, such as immune deficiencies and anemias characterized by... |
| US-5,527,775 |
Reduction of mammalian neoplasms with phospholipase A2 activating
substances Methods of treating mammalian neoplastic disease are disclosed using phospholipase A.sub.2 activating proteins and fragments thereof. |
| US-5,527,774 |
Dislocation of cataractous lens by enzymatic zonulolysis This invention is for a method of treating cataracts in eyes by couching or dislocating of the cataractous lens. It includes the steps of introducing a... |
| US-5,527,773 |
Use of synthetic peptides to disrupt the cytoskeleton Synthetic peptides corresponding to different regions of the human keratin 1 chain can disassemble preformed keratin intermediate filaments or inhibit filament... |
| US-5,527,772 |
Regulation of cell proliferation and differentiation using peptides Disclosed are methods of inhibiting proliferation and enhancing differentiation of a mammalian cell, inducing proliferation of a mammalian cell, enhancing wound... |
| US-5,527,771 |
Methods and Compositions for treatment of diabetes mellitus,
hypoglycemia & other conditions Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for... |
| US-5,527,770 |
Immunotherapeutic agent derived from bacteria An immunotherapeutic agent is prepared from cells of E. coli or members of the genus Mycobacterium. The material is effective as an anti-tumor agent, an... |
| US-5,527,769 |
Aromatic compounds and their use in perfumery The compounds of formula ##STR1## wherein symbol X represents a --CHO group or an acetal group of formula ##STR2## symbols R', taken separately,... |
| US-5,527,768 |
Use of 1-benzyl cyclohexanol in augmenting, enhancing or imparting
aromas in or to perfume compositions,... Described is the use of 1-benzyl cyclohexanol having the structure: ##STR1## in augmenting or enhancing the aroma of perfume compositions, colognes and ... |
| US-5,527,767 |
Method for annealing thin film superconductors There is disclosed a method for annealing oxide thin film superconductors having layered structures including at least Cu--O layers in which each oxide thin film... |
Copyright 2008−2012 Patents.com
